Molecular alterations in metaplastic breast carcinoma

Area of Science:

• Oncology
• Genetics
• Pathology

Background:

• Metaplastic carcinoma of the breast (MCB) is a rare, heterogeneous breast cancer subtype.
• MCB typically presents as larger tumors with less nodal metastasis than invasive ductal carcinoma.
• MCB often lacks hormone and HER2 receptor expression, limiting standard treatment efficacy.

Purpose of the Study:

• To review the pathogenesis theories of metaplastic breast carcinoma.
• To highlight known genetic alterations in MCB.
• To identify potential therapeutic targets for improved treatment strategies.

Main Methods:

• Literature review of metaplastic breast carcinoma.
• Analysis of genetic changes in MCB subsets.
• Discussion of molecular alterations and therapeutic targets.

Main Results:

• MCB exhibits distinct clinical and morphological characteristics.
• Some actionable genetic alterations have been identified in subsets of MCB.
• Further characterization of the genetic basis is crucial for new treatment development.

Conclusions:

• Metaplastic breast carcinoma has a generally poor outcome and few therapeutic options.
• Understanding the genetic landscape of MCB is essential for identifying novel therapeutic targets.
• Continued research into MCB pathogenesis and molecular alterations is needed.